emtricitabine + tenofovir disoproxil fumarate + estradiol

This is a hypothetical or non-standard combination drug consisting of three active ingredients: - Emtricitabine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors (NRTIs) used together as antiretroviral agents for the treatment and prevention (PrEP) of HIV-1 infection. They work by inhibiting the reverse transcriptase enzyme, thereby blocking HIV replication[3][5][8]. - Estradiol is a form of estrogen, a hormone primarily used in hormone replacement therapy, contraception, and gender-affirming therapy. It acts mainly through activation of estrogen receptors. There is no evidence that this specific triple combination—emtricitabine + tenofovir disoproxil fumarate + estradiol—is an approved or marketed pharmaceutical product. Emtricitabine/tenofovir disoproxil fumarate is widely available as Truvada for HIV treatment and PrEP[2][3][6], while estradiol is available separately for hormonal indications.

Other names

Truvada + estradiol